Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A.
Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
1974
ISSN/ISBN: 0034-5164 PMID: 4373807 Document Number: 74368
Document emailed within 1 workday
Related Documents
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Cayeux, S.J.; Beverley, P.C.; Schultz, R.; Dörken, B. 1993: Elevated post-stimulatory intracellular adenosine 3,5-cyclic monophosphate (cAMP) levels are found in peripheral blood cells after ABMT Bone Marrow Transplantation 11(6): 483-488
Viggiano, M.; Faletti, A.; Gimeno, M.A.; Gimeno, A.L. 1988: Influence of estrogens on in vivo and in vitro rat uterine motility. Relationships with histamine, cimetidine and tissue levels of 3',5' cyclic adenosine monophosphate Methods and Findings in Experimental and Clinical Pharmacology 10(4): 247-252
Babeş, L.; Gagheş, A.; Orăşanu, M.; Teletin, N.; Petraşincu, D.E.; Codău, M. 1992: Effect of prostaglandin E2 (PGE2) and cyclic adenosine monophosphate (cAMP) upon actin cytoskeleton in human pulmonary fibroblasts (ICP-23) infected by measles virus Roumanian Archives of Microbiology and Immunology 51(4): 239-251
Volicer, L.; Hurter, B.P. 1977: Effects of acute and chronic ethanol administration and withdrawal on adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate levels in the rat brain Journal of Pharmacology and Experimental Therapeutics 200(2): 298-305
Schmidt, M.J.; Sawyer, B.D.; Truex, L.L.; Marshall, W.S.; Fleisch, J.H. 1985: LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate Journal of Pharmacology and Experimental Therapeutics 232(3): 764-769
Zhikharev, S.S. 1977: Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma Terapevticheskii Arkhiv 49(3): 131-135
McNeill, J.H.; Verma, S.C. 1974: Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate Journal of Pharmacology and Experimental Therapeutics 188(1): 180-188
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267
Kul'chitskiĭ, O.K. 1980: Effect of acetylcholine on cyclic guanosine monophosphate levels in the hearts of rats of different ages Biulleten' Eksperimental'noi Biologii i Meditsiny 90(9): 318-319
Polson, J.B.; Goldberg, N.D.; Shideman, F.E. 1977: Norepinephrine- and isoproterenol- induced changes in cardiac contractility and cyclic adenosine 3':5' -monophosphate levels during early development of the embryonic chick Journal of Pharmacology and Experimental Therapeutics 200(3): 630-637
Grund, V.R.; Goldberg, N.D.; Hunninghake, D.B. 1975: Histamine receptors in adipose tissue: involvement of cyclic adenosine monophosphate and the H2-receptor in the lipolytic response to histamine in isolated canine fat cells Journal of Pharmacology and Experimental Therapeutics 195(1): 176-184
Hunt, W.A.; Redos, J.D.; Dalton, T.K.; Catravas, G.N. 1977: Alterations in brain cyclic guanosine 3':5'-monophosphate levels after acute and chronic treatment with ethanol Journal of Pharmacology and Experimental Therapeutics 201(1): 103-109
Weth, G. 1983: The influence of piracetam on the cyclic adenosine monophosphate (cAMP) concentration in the brain and colon of guinea pigs Arzneimittel-Forschung 33(6): 812-814
Yang, Y.; Wang, W.-S.; Qiu, Y.; Sun, L.-H.; Yang, H. 2013: Role of cyclic adenosine monophosphate(cAMP) in the regulation of intestinal epithelial barrier function under hypoxia Zhonghua Wei Chang Wai Ke Za Zhi 16(5): 479-483
O'Callaghan, J.P.; Chess, Q.; McKimmey, C.; Clouet, D.H. 1979: The effects of opiates on the levels of cyclic 3':5'-guanosine monophosphate in discrete areas of the rat central nervous system Journal of Pharmacology and Experimental Therapeutics 210(3): 361-367
Peterson, E.W.; Leblanc, R.; Lebel, F. 1975: Cyclic adenosine monophosphate antagonism of prostaglandin induced vasospasm Surgical Neurology 4(6): 490-496
Vesin, M.F.; Khac, L.D.; Harbon, S. 1979: Prostacyclin as an endogenous modulator of adenosine cyclic 3',5'-monophosphate levels in rat myometrium and endometrium Molecular Pharmacology 16(3): 823-840